Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy

Luca Scafuri, Giuseppe Di Lorenzo, Francesco Sabbatino et al.|Oncology and Therapy|2024

Cited by 0